4Siemako KF, Chong AS, Williams JW, et al. Regulation of cell function by the immanosuppressive agent leflunomide. Transplantation, 1996,61:2635 - 2642.
4Green S,Watanabe K,Braatz-Trulson,et al.Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.Biochem Pharmacol,1995,50(6):861-867.
5Xu X,Williams JW,Bremer EG,et al.Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent,leflunomide.J Biol Chem,1995,270(21):12398-12403.
6Manna SK,Aggarwal BB.Immunosuppressive lefunomide metabolite (A771726) blocks TNF-dependent muclear factor-kappa B activation and gene expression.J Immunol,1999,162(4):2095-2102.
7Kessel A,Toubi E.Leflunomide in systemic lupus erythematosus.Harefuah,2002,141(4):355-357,409.
8Breedveld FC,Dayer JM.Leflunomide:mode of action in the treatment of rhumatiod arthritis.Ann Rheum Dis,2000,59(11):841-849.
9胡伟新，肾脏病与透析肾移植杂志，2000年，9卷，3页
10Amitabyh P. Leflunomide: a review of its use in active rheumatoid arhtritis. Drugs, 1999, 58 (6): 1137-1164
